Breakthrough technology has emerged which allows the navigation of a catheter tip through a tortuous channel, such as those found in the pulmonary system, to a predetermined target. This technology compares the real-time movement of a locatable guide (LG) against a three-dimensional digital map of the targeted area of the body (for purposes of explanation, the pulmonary airways of the lungs will be used hereinafter, though one skilled in the art will realize the present invention could be used in any body cavity or system: circulatory, digestive, pulmonary, to name a few).
Such technology is described in U.S. Pat. Nos. 6,188,355; 6,226,543; 6,558,333; 6,574,498; 6,593,884; 6,615,155; 6,702,780; 6,711,429; 6,833,814; 6,974,788; and 6,996,430, all to Gilboa or Gilboa et al.; U.S. Published Applications Pub. Nos. 2002/0193686; 2003/0074011; 2003/0216639; 2004/0249267 to either Gilboa or Gilboa et al; as well as U.S. patent application Ser. No. 11/939,537 to Averbuch et al. All of these references are incorporated herein in their entireties.
Using this technology begins with recording a plurality of images of the applicable portion of the patient, for example, the lungs. These images are often recorded using CT technology. CT images are two-dimensional slices of a portion of the patient. After taking several, parallel images, the images may be “assembled” by a computer to form a virtual three-dimensional model of the lungs.
The physician then takes this virtual model and, using the software supplied with the navigation system, plans a path to the target. Planning the path to the target involves creating a patient file and selecting and saving various waypoints along the path to the target. The physician also selects and saves various registration points used by the software to register the virtual model to the actual patient in the upcoming procedure.
Typically, there is only one path that leads to the target, unless the target is very large. In the airways and vasculature of the body, the body lumina do not split and then rejoin downstream. The branches of a tree provide a good analogy: for any given leaf on a tree, there is only one combination of branches that lead to that leaf. Hence, the step of pathway planning is a time-consuming step that would be avoided if automated.
Additionally, the present systems provide guidance to the target, but not necessarily to the waypoints along the way. Instead of focusing on the target, it would be advantageous to provide navigation guidance to each of the intermittent waypoints, thereby treating each successive waypoint as a target, then, after the waypoint is reached, changing the target to the next waypoint.
In view of the foregoing, one aspect of the present invention provides a system and method for automatically planning a pathway from an entry point in a patient to a target through a luminal network.
Another aspect of the present invention automatically generates the various waypoints between a starting point and the target.
Another aspect of the present invention provides a system and method for providing navigational cues to a target via the plurality of waypoints. The cues are provided in such a manner that the next waypoint in a path is automatically detected and treated as a destination. Navigational cues are provided to that waypoint until it is reached. The system then selects the next waypoint along the path and provides navigational cues to that waypoint. This continues until the actual target is reached.
Generally, the present invention includes a system and method for constructing, selecting and presenting pathway(s) to a target location within an anatomical luminal network in a patient. The present invention is particularly, but not exclusively, suited for guiding and navigating a probe through the bronchial airways of the lungs. The present invention includes a preoperative and an operative component. The preoperative component is conducted prior to navigation and can be categorized as “Pathway Planning.” The operative component is conducted during navigation and can be categorized as “Navigation.”
Pathway Planning
The pathway planning phase includes three general steps, each of which is described in more detail below. The first step involves using a software graphical interface for generating and viewing a three-dimensional model of the bronchial airway tree (“BT”). The second step involves using the software graphical interface for selection of a pathway on the BT, either automatically, semi-automatically, or manually, if desired. The third step involves an automatic segmentation of the pathway(s) into a set of waypoints along the path that can be visualized on a display. It is to be understood that the airways are being used herein as an example of a branched luminal anatomical network. Hence, the term “BT” is being used in a general sense to represent any such luminal network, and not to be construed to only refer to a bronchial tree, despite that the initials “BT” may not apply to other networks.
First Step—BT Generation
Referring now to
At 22 the software processes the CT scans and assembles them into a three-dimensional CT volume by arranging the scans in the order they were taken and spacing them apart according to the setting on the CT when they were taken. The software may perform a data fill function to create a seamless three-dimensional model.
At 24, the software uses the newly-constructed CT volume to generate a three-dimensional map, or BT, of the airways. The three dimensional map can either be skeletonized, such that each airway is represented as a line, or it may be include airways having dimensions representative of their respective diameters. Preferably, when the BT is being generated, the airways are marked with an airflow direction (inhalation, exhalation, or separate arrows for each) for later use during the pathway generation step. It is envisioned that this step is optional. The CT volume may be used as it is.
At 26, the software displays a representation of the three-dimensional map on a user interface, such as a computer monitor.
Second Step—Pathway Selection
Referring now to
In one embodiment, the software includes an algorithm that does this by beginning at the selected target and following lumina back to the entry point. Using the airways as an example, the target is first selected. The software then selects a point in the airways nearest the target. If the point closest to the target is in an airway segment that is between branches, the software has to choose between two directional choices. If the airways of the BT were marked with airflow direction, the software moves in the opposite direction of the arrows, thereby automatically generating a pathway to the entry point.
Alternatively, the pathway to the target may be determined using airway diameter. Moving toward the entry point (the trachea) results in an increased airway diameter while moving distally results in a decreased airway diameter. Hence, the software could choose to move in the direction of increased airway diameter. If the point closes to the target is in an airway segment that includes one or more branches, the choices are more numerous but the following the path of the greatest increase in airway diameter will still result in the correct path to the entry point.
Though unlikely, in the event that an incorrect path is taken, the software would eventually detect an inevitable decrease in diameter, if this is the case, the software would automatically abort that path and revert to the last decision-making point. The algorithm will resume, blocking off the incorrect path as an option.
At 42, after the pathway has been determined, or concurrently with the pathway determination, the suggested pathway is displayed for user review. Preferably, the entire BT will be displayed with the suggested pathway highlighted in some fashion. The user will have zoom and pan functions for customizing the display.
At 44, the user is given the opportunity to edit and confirm the pathway. There may be reasons an alternative pathway is desirable. For example, though the targeted lesion is closest to a particular airway, there may be an artery or a lobe division between the selected airway and the target. Hence, it is important to provide the user with editing ability.
Third Step—Waypoint Selection
Referring now to
At 62, the waypoints appear on the suggested pathway, and may be labeled in such a way as to distinguish them from each other. For example, the waypoints may be numbered, beginning at 1, in the order that they appear. Preferably, the waypoints are positioned just downstream of each bifurcation, instead of at the bifurcation. In this way, providing navigation directions to the waypoint results in the probe being positioned in the appropriate airway once the waypoint has been reached. Hence, the physician can begin navigation to the next waypoint by simply advancing the probe without being concerned about advancing down an incorrect airway.
At 64, the user is given the opportunity to edit the waypoints. It is understood that the second and third steps may occur concurrently. If the user is editing the pathway to the target, the user will also be selecting alternative waypoints, as one in the art will realize.
Fly-Through Feature
In addition to the editing features described above, the software presents a “fly-through” feature that presents the user with the opportunity to view the user interface as it would appear from start to finish if the procedure was performed as planned. A preferred embodiment of one view the user interface is shown in
The interface 80 is divided into four quadrants, 82, 84, 86 and 88. The upper-left quadrant 82 is a lateral view of the CT volume of the lungs, i.e. as though looking parallel to the spine of the patient. The lower-left quadrant 84 is a birds-eye view of the CT volume of the lungs. The upper-right quadrant 86 is a side view of the CT volume of the lungs. The lower-right quadrant 88 is a three-dimensional perspective view inside a virtual airway of the BT. Cross-hairs 90 span over all of the quadrants to show the present location of the LG. The cross-hairs 90 in quadrant 88 are shown in a perspective format.
Navigation
The heading “Navigation” refers to the processes occurring during the actual procedure. Referring now to
Quadrant 108 is shown as displaying an LG steering indicator. The destination 110 appears as a circle which floats over the quadrant 108 and moves when the LG is turned. The destination 110 represents the next waypoint to which the user is navigating, or the final destination (targeted lesion) in the event that the last waypoint has been passed.
When the distal tip of the LG is pointing directly at the destination 110, the destination 110 appears in the center of the circle 112. If the LG is not pointing directly at the destination 110, the destination 110 is located in a representative location in or out of the circle 112. For example, if the LG is pointing down and right of the destination 110 in the body (in other words, the destination 110 is above and left of where the LG is pointing), the destination 110 on the display in quadrant 108 will appear above and left of the center of the circle 112. If the LG is deflected away from the destination 110 far enough, the destination 110 may not even appear in the quadrant 108. For this reason, a guide arrow 114 appears somewhere on the circle 112. The guide arrow 114 tells the user which direction the LG must be deflected to align the tip with the destination 110.
Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
This application claims priority to Patent Application Ser. No. 61/053,523, filed May 15, 2008, entitled Automatic Pathway And Waypoint Generation And Navigation Method, which is hereby incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5480422 | Ben-Haim | Jan 1996 | A |
| 5558091 | Acker et al. | Sep 1996 | A |
| 5729129 | Acker | Mar 1998 | A |
| 5752513 | Acker et al. | May 1998 | A |
| 5928248 | Acker | Jul 1999 | A |
| 6016439 | Acker | Jan 2000 | A |
| 6147480 | Osadchy et al. | Nov 2000 | A |
| 6161032 | Acker | Dec 2000 | A |
| 6188355 | Gilboa | Feb 2001 | B1 |
| 6201387 | Govari | Mar 2001 | B1 |
| 6203493 | Ben-Haim | Mar 2001 | B1 |
| 6211666 | Acker | Apr 2001 | B1 |
| 6226543 | Gilboa et al. | May 2001 | B1 |
| 6233476 | Strommer et al. | May 2001 | B1 |
| 6314310 | Ben-Haim et al. | Nov 2001 | B1 |
| 6332089 | Acker et al. | Dec 2001 | B1 |
| 6335617 | Osadchy et al. | Jan 2002 | B1 |
| 6366799 | Acker et al. | Apr 2002 | B1 |
| 6373240 | Govari | Apr 2002 | B1 |
| 6427314 | Acker | Aug 2002 | B1 |
| 6453190 | Acker et al. | Sep 2002 | B1 |
| 6484118 | Govari | Nov 2002 | B1 |
| 6558333 | Gilboa et al. | May 2003 | B2 |
| 6574498 | Gilboa | Jun 2003 | B1 |
| 6580938 | Acker | Jun 2003 | B1 |
| 6591129 | Ben-Haim et al. | Jul 2003 | B1 |
| 6593884 | Gilboa et al. | Jul 2003 | B1 |
| 6615155 | Gilboa | Sep 2003 | B2 |
| 6618612 | Acker et al. | Sep 2003 | B1 |
| 6650927 | Keidar | Nov 2003 | B1 |
| 6690816 | Aylward et al. | Feb 2004 | B2 |
| 6690963 | Ben-Haim et al. | Feb 2004 | B2 |
| 6702780 | Gilboa et al. | Mar 2004 | B1 |
| 6711429 | Gilboa et al. | Mar 2004 | B1 |
| 6788967 | Ben-Haim et al. | Sep 2004 | B2 |
| 6833814 | Gilboa et al. | Dec 2004 | B2 |
| 6947788 | Gilboa et al. | Sep 2005 | B2 |
| 6995729 | Govari et al. | Feb 2006 | B2 |
| 6996430 | Gilboa et al. | Feb 2006 | B1 |
| 7197354 | Sobe | Mar 2007 | B2 |
| 7233820 | Gilboa | Jun 2007 | B2 |
| 7236567 | Sandkamp et al. | Jun 2007 | B2 |
| 7286868 | Govari | Oct 2007 | B2 |
| 7301332 | Govari et al. | Nov 2007 | B2 |
| 7321228 | Govari | Jan 2008 | B2 |
| 7324915 | Altmann et al. | Jan 2008 | B2 |
| 7343195 | Strommer et al. | Mar 2008 | B2 |
| 7353125 | Nieminen et al. | Apr 2008 | B2 |
| 7366562 | Dukesherer et al. | Apr 2008 | B2 |
| 7370656 | Gleich et al. | May 2008 | B2 |
| 7373271 | Schneider | May 2008 | B1 |
| 7386339 | Strommer et al. | Jun 2008 | B2 |
| 7397364 | Govari | Jul 2008 | B2 |
| 7517318 | Altmann et al. | Apr 2009 | B2 |
| 7831076 | Altmann et al. | Nov 2010 | B2 |
| 20010031919 | Strommer et al. | Oct 2001 | A1 |
| 20010034530 | Malackowski et al. | Oct 2001 | A1 |
| 20020193686 | Gilboa | Dec 2002 | A1 |
| 20030074011 | Gilboa et al. | Apr 2003 | A1 |
| 20030099390 | Zeng et al. | May 2003 | A1 |
| 20030216639 | Gilboa et al. | Nov 2003 | A1 |
| 20040097804 | Sobe | May 2004 | A1 |
| 20040138548 | Strommer et al. | Jul 2004 | A1 |
| 20040249267 | Gilboa | Dec 2004 | A1 |
| 20050033149 | Strommer et al. | Feb 2005 | A1 |
| 20050085715 | Dukesherer et al. | Apr 2005 | A1 |
| 20050107688 | Strommer | May 2005 | A1 |
| 20050197566 | Strommer et al. | Sep 2005 | A1 |
| 20060058647 | Strommer et al. | Mar 2006 | A1 |
| 20060064006 | Strommer et al. | Mar 2006 | A1 |
| 20060149134 | Soper et al. | Jul 2006 | A1 |
| 20070167738 | Timinger et al. | Jul 2007 | A1 |
| 20070167743 | Honda et al. | Jul 2007 | A1 |
| 20070167806 | Wood et al. | Jul 2007 | A1 |
| 20070265639 | Danek et al. | Nov 2007 | A1 |
| 20070287901 | Strommer et al. | Dec 2007 | A1 |
| 20080033452 | Vetter et al. | Feb 2008 | A1 |
| 20080086051 | Voegele | Apr 2008 | A1 |
| 20080097187 | Gielen et al. | Apr 2008 | A1 |
| 20080118135 | Averbuch et al. | May 2008 | A1 |
| 20080132909 | Jascob et al. | Jun 2008 | A1 |
| 20080132911 | Sobe | Jun 2008 | A1 |
| 20080139915 | Dolan et al. | Jun 2008 | A1 |
| 20080147000 | Seibel et al. | Jun 2008 | A1 |
| 20080157755 | Kruger et al. | Jul 2008 | A1 |
| 20080161682 | Kendrick et al. | Jul 2008 | A1 |
| 20080162074 | Schneider | Jul 2008 | A1 |
| 20080183071 | Strommer et al. | Jul 2008 | A1 |
| 20080188749 | Rasche et al. | Aug 2008 | A1 |
| 20080247622 | Aylward et al. | Oct 2008 | A1 |
| Number | Date | Country | |
|---|---|---|---|
| 20100008555 A1 | Jan 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61053523 | May 2008 | US |